Literature DB >> 10443615

Suppression of central nervous system sodium channels by propofol.

B Rehberg1, D S Duch.   

Abstract

BACKGROUND: Previous studies have provided evidence that clinical levels of propofol alter the functions of voltage-dependent sodium channels, thereby inhibiting synaptic release of glutamate. However, most of these experiments were conducted in the presence of sodium-channel activators, which alter channel inactivation. This study electrophysiologically characterized the interactions of propofol with unmodified sodium channels.
METHODS: Sodium currents were measured using whole-cell patch-clamp recordings of rat brain IIa sodium channels expressed in a stably transfected Chinese hamster ovary cell line. Standard electrophysiologic protocols were used to record sodium currents in the presence or absence of externally applied propofol.
RESULTS: Propofol, at concentrations achieved clinically in the brain, significantly altered sodium channel currents by two mechanisms: a voltage-independent block of peak currents and a concentration-dependent shift in steady-state inactivation to hyperpolarized potentials, leading to a voltage dependence of current suppression. The two effects combined to give an apparent concentration yielding a half-maximal inhibitory effect of 10 microM near the threshold potential of action potential firing (about -60 mV). Propofol inhibition was also use-dependent, causing a further block of sodium currents at these anesthetic concentrations.
CONCLUSIONS: In these experiments with pharmacologically unaltered sodium channels, propofol inhibition of currents occurred at concentrations about eight-fold above clinical plasma levels and thus at brain concentrations reached during clinical anesthesia. Therefore, the results indicate a possible role for sodium-channel suppression in propofol anesthesia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10443615     DOI: 10.1097/00000542-199908000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  24 in total

1.  Block of voltage-operated sodium channels by 2,6-dimethylphenol, a structural analogue of lidocaine's aromatic tail.

Authors:  Gertrud Haeseler; Johannes Bufler; Sarah Merken; Reinhard Dengler; Jeffrey Aronson; Martin Leuwer
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

2.  Effect of intravenous anesthetic propofol on synaptic vesicle exocytosis at the frog neuromuscular junction.

Authors:  Luciana Ferreira Leite; Renato Santiago Gomez; Matheus de Castro Fonseca; Marcus Vinicius Gomez; Cristina Guatimosim
Journal:  Acta Pharmacol Sin       Date:  2010-11-29       Impact factor: 6.150

3.  Synaptic-type α1β2γ2L GABAA receptors produce large persistent currents in the presence of ambient GABA and anesthetic drugs.

Authors:  Ping Li; Gustav Akk
Journal:  Mol Pharmacol       Date:  2015-02-09       Impact factor: 4.436

4.  Clinical concentrations of chemically diverse general anesthetics minimally affect lipid bilayer properties.

Authors:  Karl F Herold; R Lea Sanford; William Lee; Olaf S Andersen; Hugh C Hemmings
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

5.  GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.

Authors:  Yevgenij Yanovsky; Stephan Schubring; Wiebke Fleischer; Günter Gisselmann; Xin-Ran Zhu; Hermann Lübbert; Hanns Hatt; Uwe Rudolph; Helmut L Haas; Olga A Sergeeva
Journal:  Pflugers Arch       Date:  2011-07-07       Impact factor: 3.657

6.  4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance.

Authors:  V S Eckle; C Grasshoff; V Mirakaj; P M O'Neill; N G Berry; M Leuwer; B Antkowiak
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

7.  Anesthetic management for subtotal gastrectomy in a patient with paramyotonia congenita.

Authors:  Toru Kaneda; Michiyo Iwahashi; Toshiyasu Suzuki
Journal:  J Anesth       Date:  2007-11-01       Impact factor: 2.078

Review 8.  The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.

Authors:  Yoshinori Kotani; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

9.  Oleuropein attenuates cognitive dysfunction and oxidative stress induced by some anesthetic drugs in the hippocampal area of rats.

Authors:  Masoud Alirezaei; Maryam Rezaei; Shahin Hajighahramani; Ali Sookhtehzari; Katayoun Kiani
Journal:  J Physiol Sci       Date:  2016-03-29       Impact factor: 2.781

10.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.